Inogen (INGN) Operating Expenses (2013 - 2026)

Inogen (INGN) has 14 years of Operating Expenses data on file, last reported at $47.2 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 7.2% year-over-year to $47.2 million in Q1 2026; TTM through Mar 2026 was $187.6 million, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at $184.5 million, down 6.48% from the prior year.
• Operating Expenses for Q1 2026 stood at $47.2 million, up from $44.5 million in the prior quarter.
• Over the last five years, Operating Expenses for INGN reached as high as $88.0 million in Q4 2022 and fell as low as $44.0 million in Q1 2025.
• Historically, Operating Expenses has averaged $53.2 million across 5 years, with a median of $49.1 million in 2022.
• Across the five-year window, Operating Expenses jumped 94.34% in 2022 and slumped 38.95% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $88.0 million in 2022, then tumbled by 35.04% to $57.1 million in 2023, then dropped by 16.56% to $47.7 million in 2024, then retreated by 6.57% to $44.5 million in 2025, then advanced by 5.97% to $47.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $47.2 million in Q1 2026, $44.5 million in Q4 2025, and $48.4 million in Q3 2025.